Why the study?
Does endotoxin administration impair beta-adrenergic responsiveness in isolated rat myocytes?
Does endotoxin administration impair beta-adrenergic responsiveness in isolated rat myocytes?
Endotoxin challenge blunts myocyte hormonal responsiveness, likely due to decreased adenylate cyclase activity and reduced beta-adrenergic receptor density.
Endotoxin may blunt myocyte responsiveness via receptor loss; leaves open clinical translation and therapeutic targeting in sepsis models.
A dose-dependent impairment of intrinsic myocardial performance has been observed following in vivo administration of endotoxin. The present study reports a dose-dependent increase in plasma catecholamines following endotoxin (ET) that may impair beta-adrenergic responsiveness. Hearts were removed from pentobarbital-anesthetized rats 4 h after a bolus injection of saline or ET (1,000, 100, or 10 micrograms/100 g body wt) and were studied as isolated cell preparations following collagenase digestion. Responsiveness of isoproterenol-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in myocytes prepared from hearts of animals injected with 10 and 100 micrograms ET was decreased when compared with control rats and was significantly blunted in myocytes prepared from animals receiving 1,000 micrograms ET. Similar sensitivities of the cAMP system existed, as judged by similar half-maximum effective concentration values. cAMP accumulation in the presence of 1 microM forskolin was depressed in myocytes from the 1,000-microgram ET animals; beta-adrenergic receptor density was decreased 25% (P less than 0.05) in myocytes from high-dose ET animals when compared with control animals. This was accompanied by a nonsignificant reduction in the affinity of binding sites for (+/-) [3H]CGP 12177. The blunted myocyte hormonal responsiveness following ET challenge appears to be related to the decreased activity of the adenylate cyclase that may be attributed to alterations in both receptor density and in the adenylate cyclase itself.
No takes yet. Share an insight, caveat, or question.
Shepherd et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: